379 related articles for article (PubMed ID: 23165187)
21. Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing.
Sullivan KM; Manuppello JR; Willett CE
SAR QSAR Environ Res; 2014; 25(5):357-65. PubMed ID: 24773450
[TBL] [Abstract][Full Text] [Related]
22. Evolution of the international workshops on quantitative structure-activity relationships (QSARs) in environmental toxicology.
Kaiser KL
SAR QSAR Environ Res; 2007; 18(1-2):3-20. PubMed ID: 17365955
[TBL] [Abstract][Full Text] [Related]
23. Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species.
Yan L; Gu Z; Zhao Y
Chem Asian J; 2013 Oct; 8(10):2342-53. PubMed ID: 23881693
[TBL] [Abstract][Full Text] [Related]
24. Using chemical categories to fill data gaps in hazard assessment.
van Leeuwen K; Schultz TW; Henry T; Diderich B; Veith GD
SAR QSAR Environ Res; 2009; 20(3-4):207-20. PubMed ID: 19544189
[TBL] [Abstract][Full Text] [Related]
25. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
26. Quantitative structure-activity relationship modelling of the carcinogenic risk of nitroso compounds using regression analysis and the TOPS-MODE approach.
Helguera AM; Pérez-Machado G; Cordeiro MN; Combes RD
SAR QSAR Environ Res; 2010 Apr; 21(3-4):277-304. PubMed ID: 20544552
[TBL] [Abstract][Full Text] [Related]
27. Informing mechanistic toxicology with computational molecular models.
Goldsmith MR; Peterson SD; Chang DT; Transue TR; Tornero-Velez R; Tan YM; Dary CC
Methods Mol Biol; 2012; 929():139-65. PubMed ID: 23007429
[TBL] [Abstract][Full Text] [Related]
28. Future of toxicology--predictive toxicology: An expanded view of "chemical toxicity".
Richard AM
Chem Res Toxicol; 2006 Oct; 19(10):1257-62. PubMed ID: 17040094
[TBL] [Abstract][Full Text] [Related]
29. Toward in silico approaches for investigating the activity of nanoparticles in therapeutic development.
Saliner AG; Poater A; Worth AP
IDrugs; 2008 Oct; 11(10):728-32. PubMed ID: 18828072
[TBL] [Abstract][Full Text] [Related]
30. Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR.
van Ravenzwaay B; Herold M; Kamp H; Kapp MD; Fabian E; Looser R; Krennrich G; Mellert W; Prokoudine A; Strauss V; Walk T; Wiemer J
Mutat Res; 2012 Aug; 746(2):144-50. PubMed ID: 22305969
[TBL] [Abstract][Full Text] [Related]
31. CompNanoTox2015: novel perspectives from a European conference on computational nanotoxicology on predictive nanotoxicology.
Bañares MA; Haase A; Tran L; Lobaskin V; Oberdörster G; Rallo R; Leszczynski J; Hoet P; Korenstein R; Hardy B; Puzyn T
Nanotoxicology; 2017 Sep; 11(7):839-845. PubMed ID: 28885075
[TBL] [Abstract][Full Text] [Related]
32. Toxicology of nanoparticles.
Elsaesser A; Howard CV
Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
[TBL] [Abstract][Full Text] [Related]
33. Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity.
Oksel C; Ma CY; Liu JJ; Wilkins T; Wang XZ
Adv Exp Med Biol; 2017; 947():103-142. PubMed ID: 28168667
[TBL] [Abstract][Full Text] [Related]
34. Manufactured nanomaterials: categorization and approaches to hazard assessment.
Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
36. QSAR modeling of nanomaterials.
Burello E; Worth AP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(3):298-306. PubMed ID: 21384562
[TBL] [Abstract][Full Text] [Related]
37. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
38. Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.
Soffers AE; Boersma MG; Vaes WH; Vervoort J; Tyrakowska B; Hermens JL; Rietjens IM
Toxicol In Vitro; 2001; 15(4-5):539-51. PubMed ID: 11566589
[TBL] [Abstract][Full Text] [Related]
39. Nano(Q)SAR: Challenges, pitfalls and perspectives.
Tantra R; Oksel C; Puzyn T; Wang J; Robinson KN; Wang XZ; Ma CY; Wilkins T
Nanotoxicology; 2015; 9(5):636-42. PubMed ID: 25211549
[TBL] [Abstract][Full Text] [Related]
40. Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk.
Costa PM; Fadeel B
Toxicol Appl Pharmacol; 2016 May; 299():101-11. PubMed ID: 26721310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
